adoptive T cell therapy

소개글

adoptive T cell, tumor infiltrating lymphocyte 에 관한 PPT 입니다

그림이 좋아서 도움이 될 것입니다.

목차

없음

본문내용

Introduction
Despite recent advances in the field, the prognosis of patients with AJCC stage IV melanoma remains to be very poor with a median survival below 12 months.
Adoptive T-cell therapy(ACT) with tumor-infiltrating lymphocytes(TILs) represents one of the most promising therapies in clinical development, with superior efficacy demonstrated in independent clinical trials carried out at three different institutions.

<중 략>

Introduction
Despite recent advances in the field, the prognosis of patients with AJCC stage IV melanoma remains to be very poor with a median survival below 12 months.

참고 자료

없음